BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8682288)

  • 21. A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody.
    Taniguchi Y; Tanji C; Kawai T; Saito H; Marubayashi S; Yorioka N
    Ther Apher Dial; 2006 Feb; 10(1):90-3. PubMed ID: 16556143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reversible paraneoplastic cerebellar symptoms. An example of anti-Ri syndrome].
    Pfeiffer G; Grupp C
    Nervenarzt; 1998 Jun; 69(6):516-8. PubMed ID: 9673976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antineuronal autoantibody to a 40-kDa protein in a patient with cerebellar ataxia and breast cancer].
    Kaneko A; Nishikiori E; Imai A; Hosokawa T; Hamaguchi K
    Rinsho Shinkeigaku; 1995 Mar; 35(3):277-81. PubMed ID: 7614751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer and paraneoplastic cerebellar degeneration.
    Waterhouse DM; Natale RB; Cody RL
    Cancer; 1991 Oct; 68(8):1835-41. PubMed ID: 1913530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration.
    Sindic CJ; Andersson M; Boucquey D; Chalon MP; Bisteau M; Brucher JM; Laterre EC
    Acta Neurol Belg; 1993; 93(2):65-77. PubMed ID: 8506746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraneoplastic motor neuron disease associated with Purkinje cell autoantibody type 1.
    Distad BJ; Weiss MD
    J Clin Neuromuscul Dis; 2010 Sep; 12(1):36-41. PubMed ID: 20808163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers.
    Landtblom AM; Lindvall B; Ledin T; Berlin G
    Ther Apher Dial; 2008 Feb; 12(1):82-5. PubMed ID: 18257818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M; Tanaka K; Onodera O; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration].
    Miyatake T
    Rinsho Shinkeigaku; 1993 Dec; 33(12):1291-3. PubMed ID: 8174327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.
    David YB; Warner E; Levitan M; Sutton DM; Malkin MG; Dalmau JO
    Cancer; 1996 Nov; 78(10):2153-6. PubMed ID: 8918408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Uncoupling of cerebellar blood flow and metabolism in paraneoplastic cerebellar degeneration: report of a case].
    Tanaka S; Tanaka M; Wada N; Okamoto K; Hirai S; Tanaka K
    Rinsho Shinkeigaku; 1997 Jun; 37(6):514-9. PubMed ID: 9366181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case report of plasma exchange therapy in non-paraneoplastic cerebellar ataxia associated with anti-Yo antibody.
    Meloni C; Iani C; Dominijanni S; Arciprete F; Cipriani S; Caramiello MS; Tozzo C; Lombardo PA; Tatangelo P; Cecilia A; Straccialano E; Casciani CU
    Ther Apher Dial; 2004 Dec; 8(6):500-2. PubMed ID: 15663551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer.
    Matsushita H; Kodama S; Aoki Y; Tanaka K; Tanaka K; Saito N
    Gynecol Obstet Invest; 1998; 45(2):140-3. PubMed ID: 9517809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
    PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-specific killer cells in paraneoplastic cerebellar degeneration.
    Albert ML; Darnell JC; Bender A; Francisco LM; Bhardwaj N; Darnell RB
    Nat Med; 1998 Nov; 4(11):1321-4. PubMed ID: 9809559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.